Inflammation-induced microvascular insulin resistance is an early event in diet-induced obesity.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 4613534)

Published in Clin Sci (Lond) on August 11, 2015

Authors

Lina Zhao1, Zhuo Fu1, Jing Wu2, Kevin W Aylor1, Eugene J Barrett1, Wenhong Cao3, Zhenqi Liu4

Author Affiliations

1: Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, U.S.A.
2: Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, U.S.A. Department of Endocrinology, Central South University Xiangya Hospital, Changsha, Hunan 410008, China.
3: Department of Nutrition, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27516, U.S.A.
4: Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, U.S.A. zl3e@virginia.edu).

Articles cited by this

Inflammation and insulin resistance. J Clin Invest (2006) 18.76

IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med (2005) 12.07

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science (2001) 11.56

Obesity, inflammation, and insulin resistance. Gastroenterology (2007) 7.54

Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol (2004) 6.78

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature (1998) 6.69

The global epidemic of obesity: an overview. Epidemiol Rev (2007) 5.46

The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med (2010) 3.56

The epidemic of obesity. J Clin Endocrinol Metab (2004) 3.53

Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation (2003) 3.33

Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care (2007) 2.92

Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol (2008) 2.75

Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes (2004) 2.55

Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci (2008) 2.54

Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes (2005) 2.33

Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes (2006) 2.14

Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest (1999) 2.00

Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc Natl Acad Sci U S A (2007) 1.95

Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab (2003) 1.88

Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes Res (2003) 1.79

Globular adiponectin enhances muscle insulin action via microvascular recruitment and increased insulin delivery. Circ Res (2013) 1.66

JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction. FASEB J (2010) 1.58

Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha. Diabetes (2000) 1.58

Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiology (Bethesda) (2007) 1.56

The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study. Diabetologia (2008) 1.49

Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia (2013) 1.48

Contraction stimulates nitric oxide independent microvascular recruitment and increases muscle insulin uptake. Diabetes (2007) 1.38

Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo. Diabetes (2002) 1.32

Insulin sensitivity of muscle capillary recruitment in vivo. Diabetes (2004) 1.31

Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature. J Clin Endocrinol Metab (2009) 1.30

Insulin-mediated hemodynamic changes are impaired in muscle of Zucker obese rats. Diabetes (2002) 1.26

A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance. Diabetologia (2013) 1.19

Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans. J Clin Endocrinol Metab (2010) 1.16

Angiotensin II receptors modulate muscle microvascular and metabolic responses to insulin in vivo. Diabetes (2011) 1.13

Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance. Diabetes Care (2007) 1.09

Concern Aspirin attenuates insulin resistance in muscle of diet-induced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRbeta/IRS-1 and Akt. Diabetologia (2009) 0.99

Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans. Diabetes Care (2011) 0.97

Insulin-induced microvascular recruitment in skin and muscle are related and both are associated with whole-body glucose uptake. Microcirculation (2012) 0.95

Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study. Hypertension (2014) 0.94

Protein kinase A mediates glucagon-like peptide 1-induced nitric oxide production and muscle microvascular recruitment. Am J Physiol Endocrinol Metab (2012) 0.94

Glucagon-like peptide 1 recruits muscle microvasculature and improves insulin's metabolic action in the presence of insulin resistance. Diabetes (2014) 0.92

Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury. Am J Physiol Endocrinol Metab (2007) 0.92

Ranolazine recruits muscle microvasculature and enhances insulin action in rats. J Physiol (2013) 0.89

Losartan increases muscle insulin delivery and rescues insulin's metabolic action during lipid infusion via microvascular recruitment. Am J Physiol Endocrinol Metab (2013) 0.87

Microvascular dysfunction: an emerging pathway in the pathogenesis of obesity-related insulin resistance. Rev Endocr Metab Disord (2013) 0.84

Angiotensin-(1-7) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptor. Hypertension (2014) 0.81

Early microvascular recruitment modulates subsequent insulin-mediated skeletal muscle glucose metabolism during lipid infusion. Diabetes Care (2012) 0.78